XML 60 R39.htm IDEA: XBRL DOCUMENT v3.23.4

SHARE-BASED COMPENSATION (Tables)

12 Months Ended

Oct. 31, 2023

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Allocated Share-based compensation expense disclosure

The impact on our results for share-based compensation was as follows:

			Years Ended October 31,
			2023						2022						2021
			(in millions)
Cost of products and services			$	34					$	30					$	26
Research and development			13						14						12
Selling, general and administrative			65						82						73
Total share-based compensation expense			$	112					$	126					$	111

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions

The following assumptions were used to estimate the fair value of awards granted.

			Years Ended October 31,
			2023						2022						2021
Stock Option Plan:
Weighted average risk-free interest rate			3.9%						1.5%						0.5%
Dividend yield			0.6%						0.5%						0.7%
Weighted average volatility			28%						26%						26%
Expected life			5.5 years						5.5 years						5.5 years
LTPP:
Volatility of Agilent shares			31%						29%						30%
Volatility of selected peer-company shares			22%-84%						23%-81%						24%-57%
Pair-wise correlation with selected peers			42%						41%						45%
Post-vest restriction discount for all executive awards			7.1%						6.5%						6.8%

Summary of stock option award activity

The following table summarizes employee stock option award activity of our employees and directors for 2023.

			Options Outstanding						Weighted Average Exercise Price
			(in thousands)
Outstanding at October 31, 2022			1,097						$	94
Granted			269						$	147
Exercised			(249)						$	41
Cancelled			(37)						$	142
Outstanding at October 31, 2023			1,080						$	118

Schedule of share-based compensation, shares authorized under stock option plans, by exercise price range

The options outstanding and exercisable for equity share-based payment awards at October 31, 2023 were as follows:

			Options Outstanding																								Options Exercisable
Range of Exercise Prices			Number Outstanding						Weighted Average Remaining Contractual Life						Weighted Average Exercise Price						Aggregate Intrinsic Value						Number Exercisable						Weighted Average Remaining Contractual Life						Weighted Average Exercise Price						Aggregate Intrinsic Value
			(in thousands)						(in years)												(in thousands)						(in thousands)						(in years)												(in thousands)
$40.01 - $50.00			210						1.0						$	41					13,088						210						1.0						$	41					13,088
$100.00- $110.00			311						7.0						$	110					—						177						7.0						$	110					—
$110.01 - $150.00			319						8.8						$	143					—						40						8.3						$	136					—
$150.01 & Over			240						8.0						$	161					—						80						8.0						$	161					—
			1,080						6.6						$	118					$	13,088					507						4.8						$	92					$	13,088

Schedule of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value

The following table summarizes the aggregate intrinsic value of options exercised and the fair value of options granted in 2023, 2022 and 2021:

			Aggregate Intrinsic Value						Weighted Average Exercise Price						Per Share Value Using Black-Scholes Model
			(in thousands)
Options exercised in fiscal 2021			$	34,305					$	33
Black Scholes per share value of options granted during fiscal 2021															$	26
Options exercised in fiscal 2022			$	10,765					$	38
Black Scholes per share value of options granted during fiscal 2022															$	39
Options exercised in fiscal 2023			$	25,303					$	41
Black Scholes per share value of options granted during fiscal 2023															$	47

Share-Based Payment Arrangement, Activity

The following table summarizes non-vested award activity in 2023 primarily for our LTPP and restricted stock unit awards.

			Shares						Weighted Average Grant Price
			(in thousands)
Non-vested at October 31, 2022			2,103						$	114
Granted			864						$	146
Vested			(1,096)						$	90
Forfeited			(181)						$	134
Change in LTPP shares in the year due to exceeding performance targets			199						$	79
Non-vested at October 31, 2023			1,889						$	136

X

- Definition

Tabular disclosure of share-based payment arrangement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (d)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration